January 19, 2017
Researchers identify new drug target for gastrointestinal stromal tumors
By Sharon Rosen
Article by Colette Gallagher, Public Affairs Tamas Ordog, M.D., director of the Epigenomics Program at the Mayo Clinic Center for Individualized Medicine, and Jason Sicklick, M.D., of UC San Diego Health, identified a new drug target for gastrointestinal stromal tumors. Gastrointestinal stromal tumors (GIST) are the most common sarcoma with an estimated annual incidence of […]
Tags: #Dr. Tamas Ordog, #drug target, #Gastrointestinal stromal tumors, #GI cancer, #GIST, center for individualized medicine, mayo clinic, medical research, sarcoma